In very-early-onset IBD, iNOS overexpression contributes directly to chronic mucosal damage, whereas in acute conditions like peritonitis, its role may be more limited and influenced by multiple overlapping inflammatory pathways. The gene discussed is NOS2; the disease is inflammatory bowel disease.